Lucentis and Nitroglycerin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Nitroglycerin (nitroglycerin). Common drug interactions include nephrogenic systemic fibrosis among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Nitroglycerin. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

On Aug, 12, 2026

71 people who take Lucentis and Nitroglycerin together, and have interactions are studied.

Lucentis and Nitroglycerin drug interactions.

What are the common drug interactions of Lucentis and Nitroglycerin, by gender? *:

female:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Pallor
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Pyrexia (fever)
Rectosigmoid cancer (cancer that originates in the rectum and sigmoid colon)
Renal failure chronic (long lasting kidney dysfunction)
Retinal vein occlusion (a blockage of the small veins that carry blood away from the retina)
Skin warm
Syncope (loss of consciousness with an inability to maintain postural tone)

male:

Death
Pneumonia
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Rash vesicular (rash with a small bubble)
Renal failure acute (rapid kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Rash
Malaise (a feeling of general discomfort or uneasiness)
Haemorrhage (bleeding)
Cardiac failure

What are the common drug interactions of Lucentis and Nitroglycerin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Oedema peripheral (superficial swelling)
Pallor
Pyrexia (fever)
Skin warm
Syncope (loss of consciousness with an inability to maintain postural tone)
Cardiac enzymes increased

50-59:

n/a

60+:

Pneumonia
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Abnormal sensation in eye
Anaemia (lack of blood)
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Arthralgia (joint pain)
Arthropathy
Conjunctivitis (pink eye)
Cystoid macular oedema (fluid accumulation after cataract surgery)
Macular cyst (retinal hole)

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 16 people, 22.54%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 7 people, 9.86%
Diabetes: 5 people, 7.04%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Nitroglycerin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously